Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
1.180
-0.020 (-1.67%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $4.38 million as of September 17, 2025. Its market cap has increased by 16.31% in one year.
Market Cap
4.38M
Enterprise Value
100.09M
1-Year Change
16.31%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $8.96M to $4.38M, a decrease of -51.12%. That is a compound annual growth rate of -2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 4.46M | 45.25% |
| Dec 31, 2024 | 3.07M | -6.42% |
| Dec 29, 2023 | 3.28M | -56.55% |
| Dec 30, 2022 | 7.55M | 26.22% |
| Dec 31, 2021 | 5.98M | -62.47% |
| Dec 31, 2020 | 15.93M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |